BPG is committed to discovery and dissemination of knowledge
Brief Article
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 21, 2009; 15(47): 5953-5959
Published online Dec 21, 2009. doi: 10.3748/wjg.15.5953
Table 4 Prescription of NSAIDs to patients in each of the two study phases of the educational program n (%)
Drug therapyPhase I
Phase II
Before visitAfter visitBefore visitAfter visit
No NSAID therapy718 (41.45)162 (9.35)653 (37.92)190 (11.03)
NSAID therapy1014 (58.55)1570 (90.65)1069 (62.08)1532 (88.97)
Aceclofenac146 (8.43)248 (14.32)b148 (8.59)202 (11.73)b
Celecoxib45 (2.60)100 (5.77)b35 (2.03)116 (6.74)b
Diclofenac229 (13.22)271 (15.65)238 (13.82)270 (15.68)
Etoricoxib16 (0.92)46 (2.66)b18 (1.05)79 (4.58)b
Ibuprofen281 (16.22)432 (24.94)b297 (17.25)406 (23.58)b
Indomethacin63 (3.64)62 (3.58)73 (4.24)75 (4.36)
Ketorolac15 (0.87)25 (1.44)28 (1.63)31 (1.80)
Meloxicam71 (4.10)234 (13.51)b101 (5.87)215 (12.49)b
Piroxicam74 (4.27)75 (4.33)64 (3.72)64 (3.72)
Other NSAIDs includes aproxen)19 (1.10)22 (1.27)16 (0.93)28 (1.63)
Analgesics
Paracetamol137 (7.91)120 (6.93)136 (7.90)122 (7.08)
Metamizol35 (2.02)28 (1.62)53 (3.08)26 (1.51)
Total1732 (100)1722 (100)


Write to the Help Desk